Modipafant | Interleukin Related interleukin-related.com

Product Name :
Modipafant

Search keywords :
Modipafant

drugId :
null

Target Vo:
Platelet activating factor receptor

Target Vo Short Name :
PAFR

Moa_Name:
Platelet activating factor receptor antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
60 Degrees Pharmaceuticals Llc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Dengue

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PAK2 (YP7071) Mouse mAb web
Sofituzumab web
BRD2 Antibody: BRD2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 88 kDa, targeting to BRD2. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts